The α9α10 Nicotinic Acetylcholine Receptor Antagonist αO-Conotoxin GeXIVA[1,2] Alleviates and Reverses Chemotherapy-Induced Neuropathic Pain

DARK Classics in Chemical Neuroscience: Morphine

(2018) Andrea L. Devereaux et al.   ACS Chemical Neuroscience

The wonderland of neuronal nicotinic acetylcholine receptors

(2018) Daniel Bertrand et al.   BIOCHEMICAL PHARMACOLOGY

Pain therapeutics from cone snail venoms: From Ziconotide to novel non-opioid pathways

(2018) Helena Safavi-Hemami et al.   Journal of Proteomics

Involvement of pro-inflammation signal pathway in inhibitory effects of rapamycin on oxaliplatin-induced neuropathic pain

(2018) Zongsheng Duan et al.   Molecular Pain

Commentary: Nicotinic Acetylcholine Receptor α9 and α10 Subunits Are Expressed in the Brain of Mice

(2018) Barbara J. Morley et al.   Frontiers in Cellular Neuroscience

Mitochondrial Nicotinic Acetylcholine Receptors Support Liver Cells Viability After Partial Hepatectomy

(2018) Kateryna Uspenska et al.   Frontiers in Pharmacology

Recent progress in non-opioid analgesic peptides

(2018) M. Jesús Pérez de Vega et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Deletion of nicotinic acetylcholine receptor alpha9 in mice resulted in altered bone structure

(2018) Lisa Baumann et al.   BONE

Nicotinic acetylcholine receptors in neuropathic and inflammatory pain

(2017) Arik J. Hone et al.   FEBS LETTERS

Nicotinic modulation of descending pain control circuitry

(2017) Iboro C. Umana et al.   PAIN

Inhibition of α9α10 nicotinic acetylcholine receptors prevents chemotherapy-induced neuropathic pain

(2017) Haylie K. Romero et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

RgIA4 Potently Blocks Mouse α9α10 nAChRs and Provides Long Lasting Protection against Oxaliplatin-Induced Cold Allodynia

(2017) Sean B. Christensen et al.   Frontiers in Cellular Neuroscience

Canonical and Novel Non-Canonical Cholinergic Agonists Inhibit ATP-Induced Release of Monocytic Interleukin-1β via Different Combinations of Nicotinic Acetylcholine Receptor Subunits α7, α9 and α10

(2017) Anna Zakrzewicz et al.   Frontiers in Cellular Neuroscience

Nicotinic Acetylcholine Receptor α9 and α10 Subunits Are Expressed in the Brain of Mice

(2017) Olena Lykhmus et al.   Frontiers in Cellular Neuroscience

Methods Used to Evaluate Pain Behaviors in Rodents

(2017) Jennifer R. Deuis et al.   Frontiers in Molecular Neuroscience

The α9α10 nicotinic receptor antagonist α-conotoxin RgIA prevents neuropathic pain induced by oxaliplatin treatment

(2016) Alessandra Pacini et al.   EXPERIMENTAL NEUROLOGY

Anti-hypersensitive effect of intramuscular administration of αO-conotoxin GeXIVA[1,2] and GeXIVA[1,4] in rats of neuropathic pain

(2016) Xiaodan Li et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

The Effectiveness and Risks of Long-Term Opioid Therapy for Chronic Pain: A Systematic Review for a National Institutes of Health Pathways to Prevention Workshop

(2015) Roger Chou et al.   ANNALS OF INTERNAL MEDICINE

Platinum-Induced Neurotoxicity and Preventive Strategies: Past, Present, and Future

(2015) A. Avan et al.   ONCOLOGIST

Cloning, synthesis, and characterization of αO-conotoxin GeXIVA, a potent α9α10 nicotinic acetylcholine receptor antagonist

(2015) Sulan Luo et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Nicotinic receptor modulation to treat alcohol and drug dependence

(2015) Shafiqur Rahman et al.   Frontiers in Neuroscience

Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline

(2014) Dawn L. Hershman et al.   JOURNAL OF CLINICAL ONCOLOGY

Incidence, prevalence, and predictors of chemotherapy-induced peripheral neuropathy: A systematic review and meta-analysis

(2014) Marta Seretny et al.   PAIN

α-Conotoxin RgIA protects against the development of nerve injury-induced chronic pain and prevents both neuronal and glial derangement

(2014) Lorenzo Di Cesare Mannelli et al.   PAIN

TRP Channels and Pain

(2013) David Julius   Annual Review of Cell and Developmental Biology

Differential modulation of EAE by α9*- and β2*-nicotinic acetylcholine receptors

(2013) Alain R Simard et al.   IMMUNOLOGY AND CELL BIOLOGY

Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)

(2013) Yaqin Han et al.   Frontiers in Pharmacology

Nicotinic receptor and tobacco-related cancer

(2012) Patrizia Russo et al.   LIFE SCIENCES

Nicotinic acetylcholine receptors: From basic science to therapeutics

(2012) Raymond Hurst et al.   PHARMACOLOGY & THERAPEUTICS

Hippocampal α7 nicotinic acetylcholine receptor levels in patients with schizophrenia, bipolar disorder, or major depressive disorder

(2011) Morten S Thomsen et al.   BIPOLAR DISORDERS

Role of the Cholinergic Antiinflammatory Pathway in Murine Autoimmune Myocarditis

(2011) Christoph Leib et al.   CIRCULATION RESEARCH

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors

(2011) Juliette Descoeur et al.   EMBO Molecular Medicine

The novel small molecule α9α10 nicotinic acetylcholine receptor antagonist ZZ-204G is analgesic

(2011) Joseph R. Holtman et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Neurotoxicity of Cancer Treatment

(2010) Marc C. Chamberlain   Current Oncology Reports

Improving Bioscience Research Reporting: The ARRIVE Guidelines for Reporting Animal Research

(2010) Carol Kilkenny et al.   PLOS BIOLOGY

Alpha9 nicotinic acetylcholine receptors and the treatment of pain

(2009) J. Michael McIntosh et al.   BIOCHEMICAL PHARMACOLOGY

Comparison of Oxaliplatin- and Cisplatin-Induced Painful Peripheral Neuropathy in the Rat

(2009) Elizabeth K. Joseph et al.   JOURNAL OF PAIN

Ziconotide: an update and review

(2008) Jason A Williams et al.   EXPERT OPINION ON PHARMACOTHERAPY